Business
QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)-- QuidelOrtho Corporation (NASDAQ:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies
About this update from Quidelortho Corporation
[{"type":"text","content":" SAN DIEGO--(BUSINESS WIRE)--\nQuidelOrtho Corporation (NASDAQ:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced that Douglas Bryant, President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024, in San Francisco, CA, scheduled for 12:00 p.m. ET / 9:00 a.m. PT.\n\n\nInterested parties can access the live webcast and replay on the “Events & Presentations” section of the “Investor Relations” page of QuidelOrtho’s website at https://ir.quidelortho.com/.\n\n\nAbout QuidelOrtho Corporation\n\n\nQuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.\n\n\nOffering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence.\n\n\nBuilding upon its many years of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe to forge a new diagnostic frontier. One where insights and solutions know no bounds, expertise seamlessly connects and a more informed path is illuminated for each of us.\n\n\nQuidelOrtho is advancing diagnostics to power a healthier future.\n\n\nFor more information, please visit www.quidelortho.com.\nSource: QuidelOrtho Corporation\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20231222524763/en/\n\nInvestor Contact:\nJuliet Cunningham\nVice President, Investor Relations\[email protected]\n\nMedia Contact:\nStephanie Kleewein\nCommunications Manager\[email protected]\n\n\nSource: QuidelOrtho Corporation","length":4089,"tagName":"div"}]